Lifeward Ltd. current report, 27 February 2024

Business Context and Reporting Period

This Form 8-K is a current report filed by ReWalk Robotics Ltd. (trading symbol: LFWD) on February 27, 2024. The filing announces the issuance of a press release containing financial results for the fourth quarter and the full fiscal year ended December 31, 2023. The company is incorporated in Israel and its ordinary shares are listed on the Nasdaq Capital Market.

Key Financial Metrics

The provided text serves as a notification of the results announcement and does not contain specific financial data points. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the reported period. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Material Changes

No material changes regarding financial performance or operations are detailed in this specific filing text. The document solely references the availability of the Q4 and full-year 2023 results in a separate press release.

Guidance, Outlook, and Management Commentary

  • Conference Call: Management scheduled a conference call to discuss the financial results on February 27, 2024, at 8:30 a.m. E.D.T.
  • Availability: An archived webcast of the call is available via the company's website and a third-party media server for 30 days following the event.
  • Legal Disclaimer: The information in this 8-K and the attached press release is furnished and not deemed "filed" under Section 18 of the 1934 Act, nor is it incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Verify the specific revenue, net loss, and cash burn figures in the attached Exhibit 99.1 (Press Release), as they are absent from this summary text.
  • Review the conference call transcript or webcast for management's commentary on the 2023 performance and 2024 outlook.
  • Confirm the company's liquidity position and runway based on the cash balance reported in the full financial statements.
  • Check for any updates on product approvals or regulatory milestones mentioned in the full press release.